CAS No.:7681-34-7
Name: Salyrgan theophylline
Details Introduction
TOXICITY DATA with REFERENCE：
| 1. |
scu-rat LD50:14 mg(Hg)/kg |
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394. | ||
| 2. |
ims-rat LD50:8 mg(Hg)/kg |
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394. | ||
| 3. |
scu-mus LD50:87 mg(Hg)/kg |
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394. | ||
| 4. |
ivn-mus LD50:950 mg/kg |
JPETAB Journal of Pharmacology and Experimental Therapeutics. 99 (1950),149. | ||
| 5. |
ivn-ham LD50:11 mg(Hg)/kg |
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),394. |
Consensus Reports：
Mercury and its compounds are on the Community Right-To-Know List.
SAFETY PROFILE：
A poison by subcutaneous, intramuscular, and intravenous routes. When heated to decomposition it emits very toxic fumes of Hg, Na2O, and NOx. See also MERCURY COMPOUNDS, INORGANIC; MERCURY COMPOUNDS, ORGANIC and THEOPHYLLINE.
Standards and Recommendations：
OSHA PEL: CL 0.1 mg(Hg)/m3 (skin)
ACGIH TLV: TWA 0.1 mg(Hg)/m3 (skin); BEI: 35 µg/g creatinine total inorganic mercury in urine preshift; 15 µg/g creatinine total inorganic mercury in blood at end of shift at end of workweek.
DFG MAK: Confirmed Animal Carcinogen with Unknown Relevance to Humans
NIOSH REL: (Mercury, Aryl and Inorganic) CL 0.1 mg/m3 (skin)
Analytical Methods：
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione